Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · Real-Time Price · USD
1.230
-0.030 (-2.38%)
May 20, 2026, 4:00 PM EDT - Market closed
Bone Biologics Employees
Bone Biologics had 2 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,428,944
Market Cap
2.23M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 2 | 0 | - | 2 | 0 |
| Dec 31, 2024 | 2 | 0 | - | 2 | 0 |
| Dec 31, 2023 | 2 | 0 | - | 2 | 0 |
| Dec 31, 2022 | 2 | 0 | - | 2 | 0 |
| Dec 31, 2021 | 2 | 0 | - | 2 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Valion Bio | 52 |
| Jaguar Health | 47 |
| Scinai Immunotherapeutics | 31 |
| Calidi Biotherapeutics | 29 |
| AIM ImmunoTech | 21 |
| Silexion Therapeutics | 14 |
| Biodexa Pharmaceuticals | 11 |
| Indaptus Therapeutics | 5 |
BBLG News
- 1 day ago - Bone Biologics achieves 29-month shelf life for rhNELL-1 - TheFly
- 1 day ago - Bone Biologics Achieves 29-Month Validated Shelf Life for rhNELL-1 - GlobeNewsWire
- 4 months ago - Bone Biologics summarizes key milestones achieved during 2025 - TheFly
- 4 months ago - Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook - GlobeNewsWire
- 5 months ago - Bone Biologics receives confirmation rhNELL-1 shelf life extended to 24 months - TheFly
- 5 months ago - Bone Biologics Improves Extension of rhNELL-1 Product Shelf Life to 24 Months - GlobeNewsWire
- 9 months ago - Bone Biologics CEO Issues Letter to Stockholders Highlighting Company Update and Outlook - Business Wire
- 9 months ago - Bone Biologics to Participate in the H.C. Wainwright Global Investment Conference - Business Wire